![Image1\](http://kaufman-charity.com/images/banners/slide0.jpg "Nivo-Szaki Slider\")
Invited Presentations
2014
“Urologic Oncology”, at the International Russian Speaking UrologicalSociety, American Urological Association 2014 Annual Meeting, Orlando, FL, May 2014.
“2014 AUA Residents Forum, Academic Urology Debate”, at the American Urological Association 2014 Annual Meeting, Orlando, FL, May 2014.
“Adrenal Mass: Contemporary Evaluation and Management” post graduate course at the American Urological Association 2014 Annual Meeting, Orlando, FL, May 2014.
“Kidney Cancer: Lesson from the NCI”, “Evaluation and Management of the Adrenal Mass”, St. Lawrence Urological Group Conference, Toronto, Ontario, Canada, January 24-26, 2014.
2013
“Management of Metastatic RCC. Debate. Cytoreductive Nephrectomy First”, 2013. International Conference on Kidney Cancer, October 2013, Chicago, IL
“Evaluation and Management of the Adrenal Mass”, 2013 Urology Symposium, October 2013, Carlsbad, CA.
“VHL in Clinical Practice Von Hippel-Lindau Syndrome”, 2013 Urology Symposium, October 2013, Carlsbad, CA.
“Management of a 4-10cm Renal Mass – Partial Nephrectomy”, AUA Annual Meeting, May 2013, San Diego, CA
“Multifocal Renal Tumors: Partial Nephrectomy or Multiple Ablations”, 2013 Current Concepts in Men’s Health, August 2013, Lake Placid, NY
“Update on Prostate Cancer:2013”, Conference of Oncological Urology of the CIS, April 2013, Kiev, Ukraine
“Update in the Diagnosis and Treatment of Renal Cell Carcinoma”, Conference of Oncological Urology of the CIS, April 2013, Kiev, Ukraine
2012
“Adjuvant XRT after radical prostatectomy”, Russian Association of Oncourology, October 2012, Moscow, Russia.
“What’s New in Renal Cancer”, Russian Association of Oncourology, October 2012, Moscow, Russia.
“Thematic Session: New in Oncourology”, Russian Association of Oncourology, October 2012, Moscow, Russia.
“Multifocal and Bilateral Kidney Cancers – Complex Management and Genetic Syndromes”, Renal Oncology: A Hands-On and Case-Based Approach for the Urologic Health Care Team Conference, September 2012, Miami Florida.
“Recent Trends in Minimally Invasive and Robotic Surgery”, First Conference of the Egyptian Chapter of the American College of Surgeons, September 2011, Cairo Egypt
“Upper Tract Transitional Cell Carcinoma: New Standards of Care”, International Urologic Oncology Symposium, August 2012, Roswell Park Cancer Institute, Buffalo, New York
“Ablative Therapies are Best”, Current Concepts in Men’s Health 2012, August 2012, The Sagamore, NY
“Partial Nephrectomy for Large Renal Masses: Looking Beyond Renal Insufficiency”, Friends of Israel Urological Symposium (FOIU), July, 2012, Tel Aviv, Israel,
“Adrenal Sparing Surgery, Indications, Techniques & Outcomes”, University of Buffalo, Roswell Park Cancer Center, June, 2012, Buffalo, NY.
“Update in the Diagnosis and Treatment of Renal Cell Carcinoma”, Conference of Oncological Urology of the CIS, April 2012, Kiev, Ukraine
“Actual issues of Diagnosis and Treatment of Locally Advanced and Metastatic Kidney Cancer, Bladder & Prostate Cancer”, Conference of Oncological Urology of the CIS, April 2012, Kiev, Ukraine
“Ablation (RFA, Cryo) of Small Renal Masses”, UCLA State of the Art Urology Conference, March 2012, Los Angeles, CA
“Nephron Sparing Surgery, Robotic/Laparoscopic vs. Open”, UCLA State of the Art Urology Conference, March 2012, Los Angeles, CA
“Robotic Kidney Surgery Tips and Tricks”, UCLA State of the Art Urology Conference, March 2012, Los Angeles, CA
“Best of Journals Session:Renal Cancer” 2012 GU ASCO Genitourinary Cancer Symposium, February 2012, San Francisco, CA
“Adrenal Sparing Surgery for Pheochromocytoma: Indications, Techniques And Outcomes”, 10th International VHL Medical Conference, January 2012 Houston, TX.
2011
“Treatment of Localized Kidney Cancer: Lessons for NCI”, 2011 Annual Northeastern Section AUA Meeting, Oct 2011, New Orleans, LA.
“Robotics in RCC Surgery”, 10th International Kidney Cancer Symposium, Kidney Cancer Association, October 2011, Chicago, Illinois
“Localized Prostate Cancer – Diagnosis, Treatment Options and New Directions In 2011”, 7th Annual Upstate Cancer Symposium,September 2011, SUNY Upstate Medical University
“Kidney Cancer Think Tank, Young Minds in Kidney Cancer”. Kidney Cancer Association, Chicago Illinois, Sept 2011
“Expanding the Rationale for Partial Nephrectomy: Looking Beyond Renal Insufficiency”, Current Concepts in Men’s Health 2011, The Sagamore, Lake George, NY.
“Choosing the treatment of prostate cancer: ablative technology versus radical prostatectomy”, Conference on the Role of Minimally Invasive Therapies in Prostate and Kidney Cancer, March 2011, Moscow, Russia.
“Comparison of treatment modalities for treatment of localized renal carcinoma: open versus laparoscopic or robotic partial nephrectomy versus ablative technologies”, Conference on the Role of Minimally Invasive Therapies in Prostate and Kidney Cancer, March 2011, Moscow, Russia.
2010
”Partial nephrectomy for tumors greater than 7cm”, Eleventh Annual Meeting of the Society of Urologic Oncology. December 2010, Bethesda, MD.
“Effects of preaquisition variables on molecular profiling of renal cell carcinoma”, Biorepository Research Network Scientific Steering Committee, National Institutes of Health, October 2010, Bethesda, MD.
“The NCI experience with partial nephrectomy”, First Western New York & Southern Ontario Kidney Cancer Symposium (by Roswell Park Cancer Institute). October 2010, Lewiston, NY.
“Dealing with focal treatment failures”, Third International Workshop on Focal Therapy and Imaging of Prostate and Kidney Cancer, February 2010, Washington DC.
2009
“Minimally invasive partial nephrectomy for T1b renal tumors”, Tenth Annual Meeting of the Society of Urologic Oncology. December 2009, Bethesda, MD.
“Genetic RCC syndromes and multifocal disease”, NYU Postgraduate Course on Surgical, Pharmacological, and Technological Advances in Adult and Pediatric Urology. December 2009, New York, NY.
“Diagnosing and dealing with ablation failures”, NYU Postgraduate Course on Surgical, Pharmacological, and Technological Advances in Adult and Pediatric Urology, December 2009, New York, NY
“Management of multifocal renal cell carcinoma”, Lecture during visiting professorship in State University of New York Syracuse Medical Center Hospital. Nov 2009, Syracuse, NY.
“Surgical management of renal cell carcinoma”, Second International Congress on Kidney Cancer, October 2009, St Petersburg, Russia.
“Von Hippel Lindau”, Second International Congress on Kidney Cancer, October 2009, St Petersburg, Russia.
“Adrenal sparing surgery for pheochromocytoma”, 2009 International Patient and Health Care Professional Conference on Pheochromocytoma and Paraganglioma, October 2009, Parsippany, NJ.
“Impact of ischemia and tissue procurement conditions on gene expression in renal cell carcinoma”, Second Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science. March 2009, Bethesda, MD.
“Management of recurrent disease after surgical therapy for kidney cancer”, GU ASCO Cancer Symposium, February 2009, Orlando, Florida
2008
“Robotic-assisted partial nephrectomy: Transperitoneal Approach”, Ninth Annual SUO Meeting. December 2008, Bethesda, MD.
“Partial adrenalectomy: indications, techniques, and outcomes”, Second international conference on pheochromocytoma. September 2008, Cambridge University, Cambridge, UK.
Growth rates of hereditary clear cell carcinoma”, Annual Meeting of the American Urological Association, May, 2008, Orlando, Florida
2007
Summary of the 1st NCI-sponsored workshop on renal cancer biomarkers”, Organ Site Breakout Session: Kidney. 15th SPORE Meeting, July 2007, Baltimore, MD.
“Does type of mutation determine metastatic potential of renal cell carcinoma? NCI experience of 17 years”, Annual Meeting of the American Urological Association, May 2007, San Francisco, California